India to Philippines: Cefuroxime Export Trade Route
India has recorded 726 verified shipments of Cefuroxime exported to Philippines, representing a combined trade value of $12.9M USD. This corridor is served by 64 active Indian exporters, with an average shipment value of $17.8K USD. The leading Indian exporter is THEON PHARMACEUTICALS LIMITED, which accounts for 28% of total export value with 269 shipments worth $3.6M USD. On the buying side, AMBICA INTERNATIONAL CORPORATION is the largest importer in Philippines with $979.0K USD in purchases. The top 3 suppliers — THEON PHARMACEUTICALS LIMITED, GLOBELA LABORATORIES PRIVATE LIMITED, NECTAR LIFE SCIENCES LIMITED — together control 41% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Cefuroxime corridor is one of India's established pharmaceutical export routes, with 726 shipments documented worth a combined $12.9M USD. The route is dominated by THEON PHARMACEUTICALS LIMITED, which alone accounts for roughly 28% of all export value, reflecting the consolidated nature of India's cefuroxime manufacturing sector.
Across 64 active suppliers, the average shipment value stands at $17.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with cefuroxime's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 16.3%, placing it at rank #19 among India's top cefuroxime export destinations globally.
On the import side, key buyers of Indian cefuroxime in Philippines include AMBICA INTERNATIONAL CORPORATION, SUHITAS PHARMACEUTICALS INC, AMB HK Enterprises Inc and 101 others. AMBICA INTERNATIONAL CORPORATION is the single largest importer with 86 shipments valued at $979.0K USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ1
- Primary modeSea freight
- Top portCHAWAPAYAL ICD
Market Position
- Global rank#19
- Annual growth+16.3%
- Demand growth+15.9%
- Regulatory ease76/100
Top 10 Indian Cefuroxime Exporters to Philippines
Showing top 10 of 64 Indian suppliers exporting Cefuroxime to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | THEON PHARMACEUTICALS LIMITED Avg $13.4K per shipment | 269 | $3.6M | 28.0% |
| 2 | GLOBELA LABORATORIES PRIVATE LIMITED Avg $45.9K per shipment | 19 | $871.6K | 6.8% |
| 3 | NECTAR LIFE SCIENCES LIMITED Avg $84.8K per shipment | 10 | $847.9K | 6.6% |
| 4 | NECTAR LIFE SCIENCES LIMITED Avg $59.2K per shipment | 13 | $769.8K | 6.0% |
| 5 | THEON PHARMACEUTICALS LIMITED Avg $12.1K per shipment | 55 | $664.6K | 5.1% |
| 6 | THEON PHARMACEUTICALS LTD Avg $21.3K per shipment | 25 | $532.4K | 4.1% |
| 7 | BRAWN LABORATORIES LIMITED Avg $13.4K per shipment | 38 | $510.6K | 4.0% |
| 8 | RAINBOW LIFE SCIENCES PRIVATE LIMITED Avg $9.2K per shipment | 51 | $469.7K | 3.6% |
| 9 | GLOBELA PHARMA PRIVATE LIMITED Avg $20.9K per shipment | 20 | $418.1K | 3.2% |
| 10 | LUPIN LIMITED Avg $65.2K per shipment | 5 | $326.1K | 2.5% |
This table shows the top 10 of 64 Indian companies exporting cefuroxime to Philippines, ranked by total trade value. The listed exporters are: THEON PHARMACEUTICALS LIMITED, GLOBELA LABORATORIES PRIVATE LIMITED, NECTAR LIFE SCIENCES LIMITED, NECTAR LIFE SCIENCES LIMITED , THEON PHARMACEUTICALS LIMITED , THEON PHARMACEUTICALS LTD, BRAWN LABORATORIES LIMITED, RAINBOW LIFE SCIENCES PRIVATE LIMITED, GLOBELA PHARMA PRIVATE LIMITED, LUPIN LIMITED. THEON PHARMACEUTICALS LIMITED is the dominant supplier with 269 shipments worth $3.6M USD, giving it a 28% market share. The top 3 suppliers together account for 41% of the total trade value on this route.
Showing top 10 of 64 total Indian exporters on the India to Philippines Cefuroxime export route.
Top 10 Cefuroxime Importers in Philippines
Showing top 10 of 104 known buyers in Philippines receiving Cefuroxime shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cefuroxime in Philippines include AMBICA INTERNATIONAL CORPORATION, SUHITAS PHARMACEUTICALS INC, AMB HK Enterprises Inc, GREEN CORE PHARMA INC., ORANGE BIOTEC INC.UNIT 1405 14TH, among 104 total buyers. The largest importer is AMBICA INTERNATIONAL CORPORATION, accounting for $979.0K USD across 86 shipments — representing 8% of all cefuroxime imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AMBICA INTERNATIONAL CORPORATION | 86 | $979.0K | 7.6% |
| 2 | SUHITAS PHARMACEUTICALS INC | 40 | $747.3K | 5.8% |
| 3 | AMB HK Enterprises Inc | 13 | $722.4K | 5.6% |
| 4 | GREEN CORE PHARMA INC. | 50 | $674.3K | 5.2% |
| 5 | ORANGE BIOTEC INC.UNIT 1405 14TH | 50 | $588.0K | 4.6% |
| 6 | CITIBANK, N.A. | 4 | $544.9K | 4.2% |
| 7 | GREEN CORE PHARMA INC.NO.460,RM | 64 | $494.8K | 3.8% |
| 8 | VERHEILEN IBERICA HEALTH CARE COMPA | 15 | $494.7K | 3.8% |
| 9 | GREEN CORE PHARMA INC | 33 | $411.9K | 3.2% |
| 10 | BANK OF THE PHILIPPINE ISLANDS (HEA | 4 | $398.2K | 3.1% |
Showing top 10 of 104 Cefuroxime importers in Philippines on this route.
Top 10 Cefuroxime Formulations Imported by Philippines
Showing top 10 of 505 product formulations shipped on the India to Philippines Cefuroxime route, ranked by trade value
Philippines imports a wide range of cefuroxime formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — RITEMED 500 (CEFUROXIME AXETIL TABLETS U — accounts for $387.5K USD across 3 shipments. There are 505 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RITEMED 500 (CEFUROXIME AXETIL TABLETS U | 3 | $387.5K | 3.0% |
| 2 | EXECORE(CEFUROXIME AXETIL TABLETS USP 50 | 8 | $220.7K | 1.7% |
| 3 | EROXIME 500 CEFUROXIME AS AXETIL 500M | 1 | $179.4K | 1.4% |
| 4 | EROXIME-500 (CEFUROXIME AXETIL 500 MG TA | 1 | $161.7K | 1.3% |
| 5 | PHILCEF 250 PACK 60ML CEFUROXIME AXETIL 250 MG SUSP BATCH NO GLD23014 TO 018 AND GLD23020 MFG DT 03 2023 EXP DT 0 | 2 | $149.5K | 1.2% |
| 6 | RITEMED 500 (CEFUROXIME AXETIL TABLETS USP 500 MG), BATCH NO. UCTC24007 AND UCTC24008, MFG. DATE : JUNE- 2024 | 1 | $137.5K | 1.1% |
| 7 | RITEMED 500 (CEFUROXIME AXETIL TABLETS USP 500 MG)(15X4'S TAB)BATCH NO UCTC23013& UCTC23014 MFG DT DEC-2023 EXP DT NOV-NOS | 1 | $137.4K | 1.1% |
| 8 | RITEMED 500,(CEFUROXIME AXETIL TABLETS USP 500 MG)(15 x 4's Tab), BATCH NO: UCTC25001 To UCTC25002 ,MFG.DT:MA | 1 | $136.1K | 1.1% |
| 9 | RITEMED 500 CEFUROXIME AXETIL TABLETS USP 500 MG15x4's TABBATCH NO UCTC23009& UCTC23010 MANUFACTURING DT SEP-2023 EXP DT AUG- | 1 | $136.1K | 1.1% |
| 10 | RITEMED 500 (CEFUROXIME AXETIL TABLETS USP 500 MG), BATCH NO. UCTC24005 AND UCTC24006, MFG. DATE : JUNE- 2024 | 1 | $135.9K | 1.1% |
Showing top 10 of 505 Cefuroxime formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHAWAPAYAL ICD handles the highest volume with 104 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's cefuroxime exports to Philippines are driven primarily by a handful of large-scale manufacturers. THEON PHARMACEUTICALS LIMITED with 269 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 64 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — THEON PHARMACEUTICALS LIMITED, GLOBELA LABORATORIES PRIVATE LIMITED, NECTAR LIFE SCIENCES LIMITED — together account for 41% of total trade value on this route. The average shipment value of $17.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as execore(cefuroxime axetil tablets usp 50 and eroxime 500 cefuroxime as axetil 500m, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AMBICA INTERNATIONAL CORPORATION is the largest importer with 86 shipments worth $979.0K USD — representing 8% of all cefuroxime imports from India on this route. A total of 104 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $12.9M
- Avg. Shipment
- $17.8K
- Suppliers
- 64
- Buyers
- 104
- Transit (Sea)
- ~23 days
- Annual Growth
- +16.3%
Related Analysis
Reverse Direction
Philippines → India — Cefuroxime (Import)Other Cefuroxime Routes
Unlock the Full India to Philippines Cefuroxime Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 726 shipments on this route.
Frequently Asked Questions — India to Philippines Cefuroxime Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cefuroxime to Philippines?
The leading Indian exporters of Cefuroxime to Philippines are THEON PHARMACEUTICALS LIMITED, GLOBELA LABORATORIES PRIVATE LIMITED, NECTAR LIFE SCIENCES LIMITED. THEON PHARMACEUTICALS LIMITED holds the largest market share at approximately 28% of total trade value on this route.
Q What is the total value of Cefuroxime exports from India to Philippines?
India exports Cefuroxime to Philippines worth approximately $12.9M USD across 726 recorded shipments. The average value per shipment is $17.8K USD.
Q Which ports does India use to ship Cefuroxime to Philippines?
The most active port of origin is CHAWAPAYAL ICD with 104 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Philippines for Cefuroxime?
The average transit time for Cefuroxime shipments from India to Philippines is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Philippines Cefuroxime trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 16.3% with demand growth tracking at 15.9%. The route is ranked #19 among India's top Cefuroxime export destinations globally.
Q How many suppliers are active on the India to Philippines Cefuroxime route?
There are currently 64 active Indian suppliers exporting Cefuroxime to Philippines. The market is moderately concentrated with THEON PHARMACEUTICALS LIMITED accounting for 28% of total shipment value.
Q Who are the main importers of Cefuroxime from India in Philippines?
The leading importers of Indian Cefuroxime in Philippines include AMBICA INTERNATIONAL CORPORATION, SUHITAS PHARMACEUTICALS INC, AMB HK Enterprises Inc, GREEN CORE PHARMA INC., ORANGE BIOTEC INC.UNIT 1405 14TH. AMBICA INTERNATIONAL CORPORATION is the largest buyer with 86 shipments worth $979.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Cefuroxime.
- 2.Supplier/Buyer Matching: 64 Indian exporters and 104 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 726 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
726 Verified Shipments
64 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists